Efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: Preliminary analysis of a randomized controlled trial

Endocrine Abstracts(2021)

引用 0|浏览7
暂无评分
摘要
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
更多
查看译文
关键词
graves’,methylprednisolone,anti-baff,moderate-severe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要